Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Gabbi logo — Making late stage Breast Cancer obsolete

Gabbi

Making late stage Breast Cancer obsolete

Founded 2020 United States Portland, United States 23 employees Seed Total: $6.22M Health Care, Health and Wellness +1

General Information

Company Name Gabbi
Founded Year 2020
Location United States Portland, United States
Employees 23
Industries Health Care, Health and Wellness, Women's Health
Funding Stage Seed
Business Model B2B2C, SaaS, Platform
Revenue Model Subscription, Service Fee, Tiered Pricing
Social

BounceWatch is an independent company data service, not affiliated with Gabbi. To contact Gabbi, visit gabbi.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Gabbi compare?

A PDF of Gabbi and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Gabbi soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Gabbi

Gabbi is positioning itself as a pioneer in women's health by focusing on early detection of breast cancer to render late-stage diagnoses obsolete. Founded in 2020, the company offers a groundbreaking breast cancer risk assessment and detection solution that claims to deliver immediate and accurate results for women across all demographics.

Operating within the Health Care, Health and Wellness, and Women's Health industries, Gabbi is headquartered in the United States. The company's mission aligns closely with current trends towards personalized and preventative healthcare solutions, potentially filling a critical gap in the market for accessible and effective breast cancer diagnostics.

The company's potential is underscored by its recent $25.00K Seed Round investment on 16 September 2024, backed by the Healthworx Accelerator. This initial funding, although modest, serves as a testament to its innovative approach and market readiness.

Business keywords: Breast Cancer, Risk Assessment, Early Detection, Medical Innovation, Women's Health, Cancer Screening, Medical Diagnostics, Precision Medicine

Services & Products

breast cancer risk assessment
personalized care planning
virtual consultations with specialists
ordering and scheduling diagnostic tests
follow-up care management

Target Customers

women at risk of breast cancer employers offering healthcare benefits health systems seeking integration solutions healthcare providers women seeking personalized preventive care

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $25.00K 1
Healthworx Accelerator
16 Sep 2024
Seed Round $4.40M 10
Gaingels Goodwater Capital Female Founders Fund
Gaingels, Goodwater Capital +8
27 Oct 2022
Seed Round $1.00M 5
StartUp Health WR Hambrecht + Co
StartUp Health, WR Hambrecht + Co +3
07 Jun 2021
Debt Financing $791.00K 5
StartUp Health
StartUp Health, WR Hambrecht +3
26 May 2021
Convertible Note Undisclosed 1
Plug and Play
Plug and Play
22 Mar 2021
Pre Seed Round Undisclosed 1
Susan Solinsky
04 Feb 2021

Gabbi Alternatives & Competitors

View All Alternatives
Gabbi vs
Aspira Women's Health
Aspira Women's Health United States

Globally transforming women's health, starting with ovarian cancer.

Post-IPO Equity
66 employees
Biotechnology, Health Care
Compare Gabbi vs Aspira Women's Health
Gabbi vs
Atossa Therapeutics
Atossa Therapeutics

Providing innovative treatments for pre-cancerous breast conditions and early-stage breast cancer.

Post-IPO Equity
51-200 employees
Biotechnology, Health Care
Gabbi vs
Glooma
Glooma Portugal

Health. Care. Life.

Pre-Seed
12 employees
Health Care, Health and Wellness
View all alternatives

FAQ About Gabbi

Making late stage Breast Cancer obsolete
Gabbi was founded in 2020.
Gabbi is headquartered in Portland, United States.
Gabbi operates in Health Care, Health and Wellness and Women's Health. Its work centres on Breast Cancer, Risk Assessment, Early Detection and Medical Innovation. Its customers include women at risk of breast cancer, employers offering healthcare benefits and health systems seeking integration solutions.
Gabbi has a B2B2C, SaaS and Platform business model. Its revenue comes from Subscription, Service Fee and Tiered Pricing.
Gabbi has approximately 23 employees.
Gabbi has completed 6 funding rounds, raising a total of $6.22M. The latest funding stage is Seed.
Gabbi offers: breast cancer risk assessment, personalized care planning, virtual consultations with specialists, ordering and scheduling diagnostic tests, follow-up care management.
Top alternatives and competitors to Gabbi include Aspira Women's Health, Atossa Therapeutics, Glooma, Mercy BioAnalytics, Inc., Sisters Network. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Gabbi and Aspira Women's Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Gabbi, https://bouncewatch.com/company/gabbi, updated 22 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes